NO964552L - Benzosykloalkylazoltionderivater - Google Patents

Benzosykloalkylazoltionderivater

Info

Publication number
NO964552L
NO964552L NO964552A NO964552A NO964552L NO 964552 L NO964552 L NO 964552L NO 964552 A NO964552 A NO 964552A NO 964552 A NO964552 A NO 964552A NO 964552 L NO964552 L NO 964552L
Authority
NO
Norway
Prior art keywords
thioxo
dihydro
benzocycloalkylazolethione
triazol
substituents
Prior art date
Application number
NO964552A
Other languages
English (en)
Other versions
NO964552D0 (no
NO311720B1 (no
Inventor
Gregory R Martinez
David Bruce Repke
Philip J Teitelbaum
Keith A M Walker
Owen E Gooding
Roger L Whiting
Rekha P Bansal
Alexander V Muehldorf
Counde O'yang
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27398461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964552(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/233,655 external-priority patent/US5438150A/en
Priority claimed from US08/403,209 external-priority patent/US5538988A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO964552D0 publication Critical patent/NO964552D0/no
Publication of NO964552L publication Critical patent/NO964552L/no
Publication of NO311720B1 publication Critical patent/NO311720B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Luminescent Compositions (AREA)
  • Polarising Elements (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Detergent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pyrane Compounds (AREA)
  • Paints Or Removers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
NO19964552A 1994-04-26 1996-10-25 Benzosykloalkylazoltionforbindelser, farmasöytiske preparater og anvendelse av slike forbindelser ved fremstilling avmedikamenter NO311720B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23383594A 1994-04-26 1994-04-26
US08/233,655 US5438150A (en) 1994-04-26 1994-04-26 Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives
US08/403,209 US5538988A (en) 1994-04-26 1995-03-17 Benzocycloalkylazolethione derivatives
PCT/US1995/004783 WO1995029165A2 (en) 1994-04-26 1995-04-25 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors

Publications (3)

Publication Number Publication Date
NO964552D0 NO964552D0 (no) 1996-10-25
NO964552L true NO964552L (no) 1996-12-27
NO311720B1 NO311720B1 (no) 2002-01-14

Family

ID=27398461

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964552A NO311720B1 (no) 1994-04-26 1996-10-25 Benzosykloalkylazoltionforbindelser, farmasöytiske preparater og anvendelse av slike forbindelser ved fremstilling avmedikamenter

Country Status (21)

Country Link
EP (1) EP0757677B1 (no)
JP (1) JPH09512269A (no)
CN (1) CN1113874C (no)
AT (1) ATE243199T1 (no)
AU (1) AU687192B2 (no)
BR (1) BR9507517A (no)
CA (1) CA2188748A1 (no)
CZ (1) CZ290082B6 (no)
DE (1) DE69531102T2 (no)
DK (1) DK0757677T3 (no)
ES (1) ES2201104T3 (no)
FI (1) FI964312A (no)
HU (1) HUT76295A (no)
IL (1) IL113480A (no)
MX (1) MX9605145A (no)
NO (1) NO311720B1 (no)
NZ (1) NZ284356A (no)
PL (1) PL185959B1 (no)
PT (1) PT757677E (no)
RU (1) RU2145321C1 (no)
WO (1) WO1995029165A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749214C (en) 1997-11-21 2006-03-30 Purdue Neuroscience Company Substituted 2-aminoacetamides and the use thereof
WO1999040063A1 (fr) * 1998-02-06 1999-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux derives de l'acide hydroxamique de type azapeptide
JP4978762B2 (ja) * 2001-03-30 2012-07-18 Ｄｉｃ株式会社 シクロヘキサ−３−エン−１−オール誘導体の製造方法
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB0600709D0 (en) * 2006-01-13 2006-02-22 Portela & Ca Sa Drug combinations
JP5372771B2 (ja) 2006-12-12 2013-12-18 ビアル−ポルテア アンド シー．エイ．， エス．エイ． プロセス
AR065107A1 (es) * 2007-02-01 2009-05-13 Portevin Bernard Compuestos inhibidores de dopamina-beta-hidroxilasa
EP1977646A1 (en) * 2007-04-03 2008-10-08 Bayer CropScience AG Insecticidal hydroxyethyl thlourea derivatives
GB0708818D0 (en) 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
GB0709695D0 (en) * 2007-05-21 2007-06-27 Portela & Ca Sa Process
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
ES2667099T3 (es) 2011-06-29 2018-05-09 Bial-Portela & Ca, S.A. Procedimiento
MX355422B (es) * 2012-11-14 2018-04-18 BIAL PORTELA & Cª S A Derivados de 1,3-dihidroimidazol-2-tiona para el uso en el tratamiento de hipertension arterial pulmonar y daño pulmonar.
CN109562100B (zh) * 2016-07-28 2021-07-20 江苏亚虹医药科技股份有限公司 多巴胺β-羟化酶(DBH)抑制剂和血清素受体(5-HT)拮抗剂用于治疗癌症的用途
JOP20190050A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي
CN111479812A (zh) 2017-12-04 2020-07-31 巴尔-波特拉及康邦亚股份有限公司 多巴胺-b-羟化酶抑制剂
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
EP4285898A1 (en) 2021-01-26 2023-12-06 Jiangsu Yahong Meditech Co., Ltd. Pathway modulator, pharmaceutical composition having same, use thereof, and therapeutic method using same
CN113527108B (zh) * 2021-09-16 2022-10-25 斯芬克司药物研发（天津）股份有限公司 一种制备光学纯的5,7-二氟-1,2,3,4-四氢化萘-2-胺及其盐的方法
CN114920906B (zh) * 2022-05-23 2023-03-21 华南理工大学 一种含咪唑硫酮单元的聚氨酯及其制备方法和应用
WO2024056079A1 (zh) * 2022-09-16 2024-03-21 江苏亚虹医药科技股份有限公司 内匹司他酸加成盐的多晶型及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
EP0277384A3 (en) * 1986-12-24 1990-05-23 Janssen Pharmaceutica N.V. 1h-imidazole-5-carboxylic acid derivatives

Also Published As

Publication number Publication date
CN1113874C (zh) 2003-07-09
DE69531102T2 (de) 2004-04-29
FI964312A (fi) 1996-12-20
IL113480A0 (en) 1995-07-31
PT757677E (pt) 2003-11-28
ES2201104T3 (es) 2004-03-16
WO1995029165A3 (en) 1995-12-07
MX9605145A (es) 1997-12-31
EP0757677A1 (en) 1997-02-12
PL185959B1 (pl) 2003-09-30
NZ284356A (en) 1997-12-19
CA2188748A1 (en) 1995-11-02
EP0757677B1 (en) 2003-06-18
CN1151735A (zh) 1997-06-11
BR9507517A (pt) 1997-09-16
WO1995029165A2 (en) 1995-11-02
AU687192B2 (en) 1998-02-19
CZ310996A3 (en) 1997-06-11
ATE243199T1 (de) 2003-07-15
HUT76295A (en) 1997-07-28
HU9602946D0 (en) 1996-12-30
RU2145321C1 (ru) 2000-02-10
DE69531102D1 (de) 2003-07-24
AU2294795A (en) 1995-11-16
JPH09512269A (ja) 1997-12-09
NO964552D0 (no) 1996-10-25
PL316856A1 (en) 1997-02-17
IL113480A (en) 2000-06-29
FI964312A0 (fi) 1996-10-25
DK0757677T3 (da) 2003-10-13
CZ290082B6 (cs) 2002-05-15
NO311720B1 (no) 2002-01-14

Similar Documents

Publication Publication Date Title
NO964552L (no) Benzosykloalkylazoltionderivater
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
GB9902592D0 (en) Fungicides
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
DE69831868D1 (en) Antithrombosemittel
ES2164763T3 (es) Composiciones para el aclaramiento de la piel.
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
CA2221190A1 (en) Novel substituted taxanes and pharmaceutical compositions containing them
ES2175084T3 (es) Uso de supresores de angiogenesis para inhibir el crecimiento del pelo.
CA2073686A1 (en) N,n'-dihaloimidazolidin-4-ones
DE69705300D1 (de) Cyclopropylalkansäurederivate
ATE109787T1 (de) Latente alkylierungsubstituenten enthaltende anthracycline-analoge.
KR880009910A (ko) 리폭시게네이즈 억제 화합물
PT692028E (pt) Farmacos baseados em papilomavirus
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
ES2108422T3 (es) Combinaciones sinergicas de productos antisolares y composiciones cosmeticas y dermatologicas que las contienen.
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
MX9805023A (es) Derivados de 1-metilcarbapenem.
EP0645382A4 (en) CUMARIN DERIVATIVES AND THEIR USE.
AR004949A1 (es) Derivados de benzoil-4-pirazol, procedimiento para obtenerlos, composiciones herbicidas que los contienen y procedimientos para combatirplantas indeseables.
MX9701525A (es) Cristales de glicosidos de espiroestanilo.
RU94044457A (ru) Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees